Introduction
Dysregulated angiogenesis is the hallmark of cardiovascular diseases (CVD), with obesity and metabolic syndrome (MS) being significant contributors to CVD [1] . The metabolic syndrome is associated with excessive accumulation of central body fat. Adipose tissue produces several hormones and cytokines termed 'adipokines' having widespread metabolic effects on vascular endothelium [2, 3] . Adipokines also appear to play important roles in the pathogenesis of insulin resistance, diabetes, and atherosclerosis [4] . Moreover, modulation of neo-angiogeneic responses of adipokines has been convincingly demonstrated within adipose tissue, further establishing the link between MS and CVD [5] .
Chemerin is a recently discovered 16-kDa adipokine and chemoattractant protein that serves as a ligand for the G protein-coupled receptor, CMKLR1 (ChemR23), with a role in adaptive and innate immunity [6, 7] . Furthermore, chemerin is elevated in obesity and shows strong correlation with various facets of the MS, including dyslipidaemia and hypertension; we have recently shown serum and adipose tissue chemerin levels to be increased in women with MS [8, 9] . Others, have reported elevated levels of circulating chemerin in inflammatory states, such as subjects with rheumatoid arthritis who are reported to have increased CVD; inflammation being a key player in immune mediated atherosclerosis [10, 11] .
Recently, the chemerin/ChemR23 system has been implicated in mediating cellular migration under inflammatory conditions [12] , a prerequisite of endothelial angiogenesis. This is of interest, as it is increasingly evident from the literature that adipokines play a significant role in the induction of atherogenesis and dysregulated angiogenesis [13, 14] . However, no studies to date have described the presence of ChemR23 in human endothelial cells (ECs) and its role in endothelial angiogenesis.
With the aforementioned, we sought to investigate the possible interplay between chemerin/ChemR23 system and the human endothelium. In the present study, we found and report for the first time the presence of ChemR23 in human ECs, and its regulation by proinflammatory cytokines. More importantly, chemerin induced endothelial angiogenesis and induced multiple signalling cascades including MAPK and Akt pathways and activates endothelial gelatinases (MMP-2/9).
Materials and Methods

Cell Culture and Treatments
Human Microvascular Endothelial Cells (HMECs) were obtained from the Centre for Disease Control (CDC) in Atlanta, Georgia, USA. Briefly HMECs were cultured in MCDB medium (Sigma-Aldrich, Dorset, UK) as described previously [15] .
For ChemR23 protein expression studies, optimization experiments were carried out by treating serum-starved ECs with or without human recombinant TNF- (0-20ng/mL) (NBS biologicals, Cambridgeshire, UK), IL-1 (0-100ng/mL) (ABCAM, Cambridgeshire, UK) and IL-6 (0-100ng/mL) (NBS biologicals, UK) in time-dependent manner (1 -24 hours).
ChemR23 blocking peptide was purchased from Sigma, UK.
RNA Isolation and Real-Time Quantitative Reverse Transcription Polymerase Chain
Reaction
Total cellular RNA was extracted using the RNeasy Mini Kit (Qiagen Ltd, UK) according to the manufacturer's protocol, followed by reverse transcription into cDNA, by using 5IU/ RevertAid H Minus M-MuLV Reverse Transcriptase (Fermentas, York, UK) as described previously [15] , as was Quantitative PCR [15] .
Protocol conditions consisted of denaturation at 94 °C for 1 min, then 38 cycles of 94 °C for 30 s, 60 °C for 45 s, and 72 °C for 30 s, followed by a 7 min extension at 72 °C.
Gene
Forward primer Reverse primer Product size 
In-Vitro Angiogenesis Assay
Angiogenesis was assessed by studying the formation of capillary-like structures by ECs on a Matrigel (BD Biosciences, San Jose, CA, USA) as described previously [15] . Briefly, serumstarved ECs were pre-treated with or without chemerin (0-30 nM) and VEGF (10ng/mL) for 24hrs. Cells were then seeded onto Matrigel coated plates at a density of 4-5 × 10 3 cells/well and incubated at 37 °C for 4, 9 or 18 hours. Capillary tube formation images were captured with a digital microscope camera system (Olympus, Tokyo, Japan). Tube lengths were quantified using Image-Pro Plus software; the length of tubes in 3-4 randomly selected fields in each of the wells was measured with the untreated groups.
Migration Assay
EC migration assay was performed according to the BD BioCoat Angiogenesis System (BD Biosciences) protocol. The assay was performed using a modified Boyden chamber as described previously [15] . Briefly, trypsinised, EC suspension of 4.0 x 10 5 cells/ml was prepared and 250 μl of which was into the transwell inserts, followed by addition of 750μl of starvation media to the lower chamber. ECs were labelled by incubating with 50 nM Calcein-AM in HBSS, for 90 minutes. The cells were treated with chemerin (0-30 nM) for 4, 8, 12 and 24 hours, VEGF served as a positive control. ECs were the fixed by 2% formaldehyde.
The migrated cells were quantified by using fluorescence plate reader.
Gelatin Zymography
The gelatinolytic activity of secreted MMP-2 and MMP-9 in the conditioned media was measured by gelatin zymography as described previously [15] . White bands were observed following de-staining indicating gelatinolytic activity of the expressed MMPs and the band intensities were measured [Gel Pro image analysis (Gel Pro 4.5, Media Cybernetics, USA)].
Western Blot Analysis
For the analyses and regulation of ChemR23 protein, serum-starved ECs were treated with or without human recombinant TNF- (0-20ng/mL), IL-1 (0-100ng/mL) and IL-6 (0-100ng/mL) in a time-dependent (1 -24 hours) manner. The protocol for protein lysates preparation and western-blot analysis was as previously described [15] , using primary anti-ChemR23 antibody (dilution 1:1000) (Santa Cruz biotechnology, Middlesex, UK), and secondary antigoat horseradish-peroxidase-conjugated Ig (1:2000) (Dako Ltd, Cambridge, UK).
Membranes were also re-probed with the β-actin antibody (Cell Signalling Technology Inc., Beverly, MA, USA; 1 in 8,000 dilution) to determine equal protein loading. Likewise, for MAPK (ERK 1/2 and p38 MAPK) and Akt activation, immunoblotting was carried out as described previously [15] .
Statistical analysis
All of the data in the present study are expressed as mean ± SEM. Comparisons among groups were made by ANOVA (non-parametric). When significance (P < 0.05) was detected, 
Results
ChemR23 Expression in Human Endothelium
RT-PCR analysis revealed the presence of ChemR23 mRNA in both micro (HMECs) and macro-vascular human ECs (HUVECs and EA.hy926) (Fig. 1A ). Western blotting, using specific chemerin receptor antibody, confirmed its expression in both these cell types as a 42 kDa band (predicted molecular weight) (Fig. 1B) . The specificity of which was further confirmed by employing a ChemR23 blocking peptide (data not shown). Additionally, immunocytochemical analysis established the presence and distribution of ChemR23 in ECs
Regulation of Endothelial ChemR23 by Proinflammatory Cytokines
Studies have elucidated the involvement of ChemR23 in chemerin induced inflammatory response/chemotaxis and specific recruitment of antigen-presenting cells to inflammatory sites [10] . Moreover, since these states are marked with increased circulating proinflammatory cytokines, we hypothesised that; TNF-, IL-1, and IL-6 may have a regulatory effect on ChemR23 expression in ECs. We incubated serum-starved ECs with dose-dependent TNF- (0-20 ng/mL), IL-1 (0-100 ng/mL) and IL-6 (0-100 ng/mL) for various time points (1-24 hours). TNF- significantly and dose-dependently increased
ChemR23 protein levels at both 12 and 24 hours (Fig 1D; ChemR23; 
P<0.001). IL-1
significantly and dose-dependently increased ChemR23 protein levels at 12 hours, with maximal response at 100ng/mL. However at 24 hours, a dose-dependent decrease in ChemR23 protein expression, with maximal response at 1ng/mL, was observed (Fig 1E; P<0.001). IL-6 like IL-1 induced a significant dose-dependent increase in ChemR23 protein expression at 12 hours with maximal response at 100ng/mL (Fig 1F; P<0.001 ).
Chemerin Induced In-Vitro Angiogenesis
Chemerin increases EC proliferation
Proliferation assay was performed in a time-dependent manner (4-48 hours) with maximal response being noted at 24 hours (data not shown). Serum starved ECs were treated with dose-dependent chemerin (0-30nM) and VEGF (10ng/mL) (positive control). At 24 hours, a significant increase in proliferation was observed at 0.1nM and 1.0 nM of chemerin and VEGF treatments [Fig 2A; 1.77 fold -VEGF (P < 0.001), and 1.41 fold-chemerin (0.1 nM) (P < 0.01) compared to basal (untreated); n=6 experiments]. These were additionally confirmed by a colorimetric Alamar-blue proliferation assay (data not shown).
Chemerin induced capillary tube formation and migration of ECs
Endothelial migration and capillary tube formation, like EC proliferation, are critical steps in Chemerin increased migration in a dose-dependent and time-dependent manner, with a maximal effect at 30 nM after 24 hours (Fig-2C1/C2 ; P<0.001 chemerin treated vs. basal);
confirming the migratory potential of chemerin in ECs. VEGF used a positive control, also significantly increased endothelial migration.
Chemerin induced MAPKinase and Akt Signalling
p38 MAPKinase and ERK 1/2 activition MAPK signalling pathways are involved in EC proliferation and specifically, p38 MAPK signalling has been documented to be critically involved in endothelial angiogenesis [16] . We investigated transient phosphorylation of p38 MAPK in EC lysates treated with both time (0-30 minutes) and dose (0-30nM) dependent chemerin. Chemerin significantly increased p38
MAPK phosphorylation, maximally at 15 minutes (Fig-3A1: 3-fold increase compared to controls P<0.001) and at 0.1 nM (Fig-3A2: 3 -fold compared to controls P<0.001).
Interestingly, higher doses of chemerin (10nM and 30nM) failed to induce any significant changes in p38 MAPK phosphorylation. phosphorylation, with maximal response at 5min, followed by a decline at 10 min, and a significant increase at 15min (Fig-3B1: P<0.001) . Additionally, chemerin (0.1 nM)
significantly increased phosphorylated ERK 1/2 (Fig-3B2 : 6-fold compared to controls;
P<0.01). However, higher doses of chemerin (10nM and 30nM) failed to induce any change in phosphorylation of ERK 1/2 . This dose specific mediated ERK 1/2 phosphorylation is particularly mirrored in chemerin induced EC proliferation, perhaps due to the vital involvement of ERK 1/2 in EC proliferation. Interestingly, chemerin had no effect on JNK activity (data not shown).
Chemerin Induced Akt signalling
As for the MAPK signalling cascades, the Akt pathway plays a critical role in angiogenesis [17] . In order to address whether chemerin activates this pathway in ECs, we treated serum starved cells with dose (0-30 nM) and time-dependent (0-30 minutes) chemerin. A significant increase in Akt phosphorylation was observed at 5 minutes (Fig-2C1: 
Chemerin-induced Gelatinolytic Activity in Human ECs
The angiogenic potential of ECs is greatly enhanced by extra-cellular matrix degradation, where gelatinases MMP-2/-9 play vital roles. To assess their involvement in chemerin induced angiogenesis, we performed gelatin zymography with the condition media of the aforementioned proliferation, migration and capillary tube formation assay (data not shown).
Chemerin dose-dependently increased both MMP-2 ( Fig-4A ; P<0.001 chemerin treated vs.
Basal) and MMP-9 ( Fig-4B ; P<0.001 chemerin treated vs. Basal) gelatinolytic activity in ECs.
Discussion
We describe novel findings, of the presence and regulation of endothelial ChemR23 by proinflammatory cytokines. More importantly, we report that chemerin, whose circulating concentrations are altered in obesity and obesity-related disorders, activates key survival and angiogenic signalling cascades like MAPK and Akt pathways. Additionally, we demonstrate for the first time chemerin induced functional angiogenesis in human ECs, by promoting migration and capillary tube formation; and activation of endothelial gelatinases (MMP-2/-9).
Altered expression of chemokines and their receptors during inflammatory processes may modify the equilibrium between angiostatic and angiogenic processes resulting in dysregulated angiogenesis leading to the development of CVD [18] . Of interest, chemerin was reported to strongly correlate with components of metabolic syndrome and pivotal inflammatory markers of CVD like TNF-, IL-6 and CRP [19] .
Studies have previously shown that up-regulation of chemokine receptors results in amplification of immunological responses by making the cells more responsive to stimuli.
Furthermore, cytokine mediated synergistic inflammatory cascades are enhanced by modulation of receptor expression for one cytokine by the other [20] [21] [22] . In our present study, we observed a significant up-regulation of the chemokine receptor ChemR23 protein expression by pro-inflammatory cytokines (TNF-, IL-1 and IL-6). Hence, given the existing pro-inflammatory environment and raised circulating cytokines in metabolic syndrome, it is tempting to propose a critical role mediated by chemerin in these inflammatory states.
At a functional level, we report chemerin induced activation of key angiogenic and cell survival cascades, namely the MAPKs and Akt pathways, in humans ECs. A significant finding in our study is the highly reproducible biphasic pattern of activation of ERK 1/2 occurring within 2 minutes, peaking at 5minutes, followed by a rapid decline at 10 minutes, and then a subsequent increase at 15 minutes. The precise explanation for this observation remains to be determined; however, similar findings in other GPCR models that trigger a biphasic feed into Ras/Raf/MEK/ERK cascade have been reported but are poorly understood [23] . The plausible pathways implicated in the biphasic response include MMP-mediated shedding of heparin-sensitive EGF receptor ligands, EGF receptor auto-phosphorylation, and MEK1 activity [23] . In this context, it is interesting to note our robust data on chemerin induced gelatinolytic activity (MMP-2/-9) in ECs. Alternatively, this time mediated termination and reappearance of signalling cascade may involve feedback loops, consisting of degradation, inactivation of proteins and differential protein trafficking [24] . Future studies are therefore required to study and elucidate these interesting chemerin induced effects on ERK1/2 and p38 MAPK pathways.
In addition, the dose-dependent effects of ERK phosphorylation were mirrored by chemerin induced EC proliferation. However, and of interest, unlike EC proliferation, both chemerin induced migration and capillary tube formation seemed to follow a dose-dependent response similar to Akt activation. Of note, activation of Akt kinase has been implicated in orchestrating a number of signalling pathways potentially involved in angiogenic processes and survival pathways [17] .
Enhanced production of MMPs, in particular gelatinases (MMP-2/-9), is an early feature of vascular remodelling and dysregulated angiogenesis, contributing to endothelial barrier dysfunction [25, 26] . Our observations of chemerin inducing functional angiogenesis, with concurrent increases in gelatinolytic activity, suggest a potential causal relationship between chemerin induced MMP activity and angiogenesis. However, future studies are required to elucidate the precise role of gelatinases in chemerin induced angiogenesis.
In conclusion, we demonstrate for the first time, presence of ChemR23 and chemerin induced in-vitro angiogenesis in human ECs. Our findings also confirm that chemerin activates key survival and angiogenic pathways including MAPK and Akt kinases. Finally, our data add to the diverse effects of chemerin, but more importantly reveal novel insights into the potential role(s) of chemerin in human EC angiogenesis. experiments. ***P < 0.001, **P < 0.01, *P < 0.05 vs. basal. ***P<0.001, **P < 0.01, *P < 0.05 vs. basal.
Figure Legends
Figure-4. Chemerin enhances MMP-2 and MMP-9 gelatinolytic activity in ECs
Chemerin enhanced gelatinolytic activity of both MMP-2/-9, when the condition media of the aforementioned capillary tube formation assay was subjected to gelatine zymography.
Figures(A) and (B) denotes representative zymograms and densitometric analysis of MMP-2
and MMP-9 protein activity in conditioned media for 24hours respectively. Results are means ± S.E.M of six independent experiments. n = 6 per group ***P<0.001, **P < 0.01, *P < 0.05 vs. basal. 
